HomeLBTSF • OTCMKTS
add
Almirall SA
Previous close
$9.51
Year range
$8.85 - $10.18
Market cap
1.77B EUR
P/E ratio
-
Dividend yield
-
Primary exchange
BME
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 222.29M | -3.57% |
Operating expense | 224.44M | 7.20% |
Net income | -52.07M | -686.74% |
Net profit margin | -23.43 | -716.38% |
Earnings per share | — | — |
EBITDA | 15.79M | -45.30% |
Effective tax rate | 3.01% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 388.09M | 55.97% |
Total assets | 2.37B | 10.58% |
Total liabilities | 911.58M | 9.97% |
Total equity | 1.46B | — |
Shares outstanding | 196.99M | — |
Price to book | 1.28 | — |
Return on assets | -0.10% | — |
Return on capital | -0.13% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | -52.07M | -686.74% |
Cash from operations | 43.38M | -14.43% |
Cash from investing | 100.34M | 324.26% |
Cash from financing | -5.70M | -11.19% |
Net change in cash | 138.03M | 16,391.16% |
Free cash flow | 129.50M | 429.73% |
About
Almirall, S.A. is a Spanish pharmaceutical company dedicated to medical dermatology, with headquarters in Barcelona, founded in 1944.
In 2022, the company generated total revenues of €878.5 million and was the leading European company in medical dermatology.
With approximately 1,800 employees, it has a direct presence in 20 countries through its 15 subsidiaries in Europe and the USA. Wikipedia
Founded
1943
Website
Employees
1,904
